Literature DB >> 16644208

Intentional and non-intentional non-adherence to medication amongst breast cancer patients.

Louise Atkins1, Lesley Fallowfield.   

Abstract

This study aimed to investigate the prevalence of and factors associated with non-adherence to medication amongst a sample of breast cancer patients. 131 women with stable disease were interviewed and completed standardised psychological measures. 55% of women reported non-adherence to medication frequently or occasionally, with younger women and those who disliked taking their medication being significantly less adherent (P = 0.015, P = 0.001). Women who deliberately omitted taking their tablets occasionally or frequently had significantly lower scores, indicative of a weaker influence, on 'internal' and 'powerful others' dimensions of health locus of control (P = 0.032, P = 0.009). Despite a life-threatening diagnosis, patients may not adhere to medication representing a potential missed opportunity for health gain and waste of resources. Furthermore, interpretation of clinical trial data may be misleading without adherence information. More research is needed to identify those at risk for non-adherence. If other routes of administration are available these options should be discussed with patients to maximise efficacy of therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644208     DOI: 10.1016/j.ejca.2006.03.004

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  67 in total

1.  Factorial invariance of a questionnaire assessing medication beliefs in Japanese non-adherent groups.

Authors:  Naomi Iihara; Kiyo Suzuki; Yuji Kurosaki; Shushi Morita; Keizo Hori
Journal:  Pharm World Sci       Date:  2010-04-16

2.  Appreciating Reasons for Nonadherence in Women.

Authors:  Jennifer G Okonsky; Allison Webel; Carol Dawson Rose; Mallory Johnson; Alice Asher; Yvette Cuca; Alphoncina Kaihura; Jan E Hanson; Carmen J Portillo
Journal:  Health Care Women Int       Date:  2014-05-15

Review 3.  Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.

Authors:  Megan C Roberts; Stephanie B Wheeler; Katherine Reeder-Hayes
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

4.  Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.

Authors:  Catherine M Bender; Amanda L Gentry; Adam M Brufsky; Frances E Casillo; Susan M Cohen; Meredith M Dailey; Heidi S Donovan; Jacqueline Dunbar-Jacob; Rachel C Jankowitz; Margaret Q Rosenzweig; Paula R Sherwood; Susan M Sereika
Journal:  Oncol Nurs Forum       Date:  2014-05       Impact factor: 2.172

5.  Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.

Authors:  E L Mayer; A H Partridge; L N Harris; R S Gelman; S T Schumer; H J Burstein; E P Winer
Journal:  Breast Cancer Res Treat       Date:  2009-03-18       Impact factor: 4.872

6.  Women's perceived control of their birth outcomes in the Central Pennsylvania Women's Health Study: implications for the use of preconception care.

Authors:  Carol S Weisman; Marianne M Hillemeier; Gary A Chase; Dawn P Misra; Cynthia H Chuang; Roxanne Parrott; Anne-Marie Dyer
Journal:  Womens Health Issues       Date:  2007-10-22

7.  Non-adherence to treatment of chronic wounds: patient versus professional perspectives.

Authors:  Christine Moffatt; Susie Murray; Vaughan Keeley; Aimee Aubeeluck
Journal:  Int Wound J       Date:  2017-08-30       Impact factor: 3.315

Review 8.  Oral antineoplastic agents: how do we care about adherence?

Authors:  Marie Barillet; Virginie Prevost; Florence Joly; Bénédicte Clarisse
Journal:  Br J Clin Pharmacol       Date:  2015-10-28       Impact factor: 4.335

9.  Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

Authors:  Erin J Aiello Bowles; Denise M Boudreau; Jessica Chubak; Onchee Yu; Monica Fujii; Janet Chestnut; Diana S M Buist
Journal:  J Oncol Pract       Date:  2012-07-17       Impact factor: 3.840

10.  Intelligence and persisting with medication for two years: Analysis in a randomised controlled trial.

Authors:  Ian J Deary; Catharine R Gale; Marlene C W Stewart; F Gerald R Fowkes; Gordon D Murray; G David Batty; Jacqueline F Price
Journal:  Intelligence       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.